Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population displaying endometrioid carcinoma at a point in time
go back to main search page
Accession:CMO:0001760 term browser browse the term
Definition:The number of individuals in a study population which display endometrioid carcinoma at a certain point in time compared to the total number of individuals in the study population, expressed as a percentage. Endometrioid carcinoma is a malignant new growth occurring in the uterine fundus and ovaries and characterized by glandular patterns resembling those of the endometrium, which is made up of epithelial cells tending to infiltrate surrounding tissues and to give rise to metastases.
Synonyms:related_synonym: endometrioid carcinoma prevalence
 xref: MESH:D018269


GViewer not supported for the selected species.

show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        endometrioid carcinoma incidence/prevalence measurement 0
          percentage of study population displaying endometrioid carcinoma at a point in time 0
            percentage of study population displaying endometrial adenocarcinomas at a point in time 0
paths to the root